Andrew Hudak

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV

Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan et al. · Cell · 2021 · 99 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Rapid, Sensitive, and Specific Lateral-Flow Immunochromatographic Point-of-Care Device for Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies in Serum and Whole Blood

Elisabeth I. Laderman, Emma Whitworth, Erickson Dumaual et al. · Clinical and Vaccine Immunology · 2007 · 98 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Remodeling of colon plasma cell repertoire within ulcerative colitis patients

Johannes F. Scheid, Basak Eraslan, Andrew Hudak et al. · The Journal of Experimental Medicine · 2023 · 34 citations · Full text

Life Sciences, Immunology, Microbiology +17